Last updated on October 2018

Patients are needed to participate in a clinical research study to evaluate Huntington's Chorea


Brief description of study

The primary objective of this study is to assess the efficacy of laquinimod 0.5, 1.0, and 1.5 mg qd in patients with HD after 12 months of treatment using the UHDRS-TMS.

Clinical Study Identifier: NCT02215616

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )